EyePoint Pharmaceuticals, Inc. ( EYPT) - Key Metrics
EYPT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$1.09 | -$1.65 | -$1.68 |
| 2026Q1 | $0.01 | -$0.99 | -$0.94 | -$0.95 |
| 2025Q4 | $0.01 | -$0.81 | -$0.78 | -$0.80 |
| 2025Q3 | $0.01 | -$0.85 | -$0.85 | -$0.86 |
| 2025Q2 | $0.08 | -$0.85 | -$0.90 | -$0.91 |
EYPT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.28 |
| 2026Q1 | 0% | -3.26 |
| 2025Q4 | 0% | -5.64 |
| 2025Q3 | 0% | -4.19 |
| 2025Q2 | 0% | -2.77 |
EYPT
Price: $14.75
52 week price:
Earnings Per Share: -3.75 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 166382
Market Capitalization: 1.1 billion